Acadia Pharmaceuticals | ACAD - Revenu Net

Prix De L'Action
21.85
Variation Quotidienne
-0.60 -2.67%
Mensuellement
-1.58%
Annuel
46.55%
Q2 Prévisions
21.49




Revenu Net Changement Date
Acadia Pharmaceuticals USD 273.57M 201.79M 2025-12
ALKERMES USD 49.34M 33.42M 2025-12
Alnylam Pharmaceuticals USD 205.99M 19.57M 2026-03
Biogen USD 319.5M 368.4M 2026-03
BioMarin Pharmaceutical USD -46.57M 15.83M 2025-12
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Cara Therapeutics USD -5.53M 621K 2025-09
Corcept Therapeutics USD -31.76M 56.05M 2026-03
Cytokinetics USD -183.03M 123.15M 2025-12
Eisai JPY 17.18B 7.02B 2025-12
Eli Lilly USD 7.4B 760M 2026-03
Incyte USD 299.28M 124.89M 2025-12
J&J USD 5.24B 119M 2026-03
Moderna USD -1.34B 517M 2026-03
Neurocrine Biosciences USD 209.5M 102M 2025-09
Pfizer USD -1.65B 5.19B 2025-12
Prothena USD -21.59M 14.95M 2025-12
PTC Therapeutics USD -134.96M 150.86M 2025-12
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
Ultragenyx Pharmaceutical USD -129M 51.41M 2025-12
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12